News
Germany defender Sarai Linder has been ruled out of her team’s Women’s European Championship semifinal against Spain, leaving ...
The Syrian government has begun evacuating Bedouin families from Sweida after over a week of violent clashes. Fighting ...
The SEC Media Days this week highlighted the ongoing rivalry between the SEC and the Big Ten in college football. SEC ...
ZimVie Inc. (“ZimVie”) (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced their entry into ...
NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announces it has successfully canceled all remaining Series A Warrants, issued in the ...
New York, July 21, 2025 (GLOBE NEWSWIRE) -- (“MFH” or the “Company”) (Nasdaq: MFH), a blockchain-powered fintech group, today announced it has entered into a $200 ...
Comprehensive review of broad pipeline targeting Alzheimer’s disease agitation, depression, narcolepsy, fibromyalgia, ADHD, and smoking cessation, with new data analyses ...
Amneal Pharmaceuticals, Inc. (“Amneal”) (Nasdaq: AMRX) announced that its subsidiary, Amneal Pharmaceuticals LLC (the “Issuer”), is seeking to borrow $1.800 billion aggregate ...
Following the FDA ODD, European designation underscores ICT01’s potential as a ...
IND cleared for the EVERLAST-A Phase 2a trial of ORKA-001 in moderate-to-severe psoriasis, with initial data expected 2H 2026 ...
Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a subscription service, has begun dispatching more than 37,000 home batteries ...
MRT-8102 Phase 1 study includes single and multiple ascending dose cohorts in healthy volunteers and is designed to evaluate safety, pharmacokinetics, NEK7 protein degradation, and other key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results